These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 1793078)

  • 1. The effects of BRL 38227 on antigen-induced extravasation and cellular infiltration into the peritoneal cavity of actively sensitised rats.
    Buckle DR; Taylor JF
    Agents Actions Suppl; 1991; 34():47-52. PubMed ID: 1793078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BRL 55 834 on allergen-induced bronchoconstriction and airway inflammation in sensitized guinea pigs.
    Shi Z; Luo W; Xiu Q; Ye Y; Yan Z; Zhu Q
    Chin Med J (Engl); 1999 Nov; 112(11):988-91. PubMed ID: 11721481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
    Imagawa J; Kamei K; Yoshida S; Sugo I; Koga T; Nabata H
    J Pharmacol Exp Ther; 1994 Apr; 269(1):1-6. PubMed ID: 8169816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
    Ando T; Kume H; Urata Y; Takagi K
    Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of SDZ PCO 400 and cromakalim on airway smooth muscle in vivo.
    Chapman ID; Mazzoni L; Morley J
    Agents Actions Suppl; 1991; 34():53-62. PubMed ID: 1793082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of inhaled cromakalim and its active enantiomer BRL 38277 as bronchodilators in the guinea-pig.
    Bowring NE; Taylor JF; Francis GR; Arch JR
    Br J Pharmacol; 1989 Dec; 98 Suppl():805P. PubMed ID: 2611518
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
    Grover GJ; Newburger J; Sleph PG; Dzwonczyk S; Taylor SC; Ahmed SZ; Atwal KS
    J Pharmacol Exp Ther; 1991 Apr; 257(1):156-62. PubMed ID: 2019983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I; Mondot S; Mestre M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
    Ichinose M; Barnes PJ
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1207-12. PubMed ID: 2108238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
    Raeburn D; Brown TJ
    J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the potassium channel activator cromakalim on human isolated bronchial smooth muscle].
    Luo Y; Liu J; Zhou L
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):149-51, 189. PubMed ID: 8565081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitussive effect of cromakalim in rats is not associated with adenosine triphosphate sensitive K+ channels.
    Kamei J; Iwamoto Y; Narita M; Suzuki T; Misawa M; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):201-10. PubMed ID: 8391711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
    Hayashi K; Matsumura Y; Yoshida Y; Ohyama T; Hisaki K; Suzuki Y; Morimoto S
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1240-6. PubMed ID: 2108239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.